• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Putting biomarkers into practice

March 8, 2023  

CNS effects of Wegovy (semaglutide)

February 28, 2023  

Putting shared decision-making into practice

February 16, 2023  

CLINICAL CASES IN MS – AN OLDER PATIENT WITH STABLE DISEASE

February 9, 2023  

The end of MS phenotypes?

January 26, 2023  

MS Awards 2022 – Oddities and Observations

December 9, 2022  

Effectiveness of COVID boosters in MS: an update

November 30, 2022  

2022 – the year in review

November 29, 2022  

CLINICAL CASES IN MS – A STABLE PATIENT WITH RISING JCV INDEX

November 17, 2022  

SPMS pathogenesis and treatment

November 14, 2022  
Previous
10
11
12
13
14
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Revised recommendations on the differential diagnosis of MS posted on July 25, 2023
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions